Astera Labs, Inc. $ALAB Shares Sold by Intech Investment Management LLC

Intech Investment Management LLC trimmed its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 57.8% in the third quarter, Holdings Channel reports. The institutional investor owned 8,894 shares of the company’s stock after selling 12,205 shares during the period. Intech Investment Management LLC’s holdings in Astera Labs were worth $1,741,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the business. Vanguard Group Inc. boosted its holdings in Astera Labs by 14.1% in the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock valued at $2,690,907,000 after purchasing an additional 1,693,918 shares in the last quarter. State Street Corp boosted its holdings in shares of Astera Labs by 39.3% in the 2nd quarter. State Street Corp now owns 2,143,459 shares of the company’s stock valued at $193,812,000 after buying an additional 604,363 shares in the last quarter. 1832 Asset Management L.P. boosted its holdings in shares of Astera Labs by 151.4% in the 2nd quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock valued at $139,563,000 after buying an additional 929,600 shares in the last quarter. Massachusetts Financial Services Co. MA grew its position in shares of Astera Labs by 46.6% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock valued at $295,203,000 after buying an additional 479,360 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in Astera Labs by 36.2% during the 2nd quarter. Geode Capital Management LLC now owns 1,244,978 shares of the company’s stock worth $112,562,000 after acquiring an additional 330,841 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Price Performance

NASDAQ:ALAB opened at $120.00 on Friday. The firm has a market cap of $20.43 billion, a price-to-earnings ratio of 98.36, a price-to-earnings-growth ratio of 2.24 and a beta of 1.74. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90. The firm’s fifty day moving average price is $153.84 and its 200 day moving average price is $170.53.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.07. The firm had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.Astera Labs’s revenue was up 91.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Transactions at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $117.47, for a total transaction of $1,174,700.00. Following the completion of the transaction, the general counsel owned 128,084 shares in the company, valued at approximately $15,046,027.48. The trade was a 7.24% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Jitendra Mohan sold 94,971 shares of the company’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the completion of the sale, the chief executive officer directly owned 1,452,739 shares in the company, valued at $179,863,615.59. This trade represents a 6.14% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 216,792 shares of company stock worth $26,777,569. Corporate insiders own 12.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. Barclays set a $165.00 price objective on shares of Astera Labs in a research note on Thursday, January 15th. Raymond James Financial started coverage on Astera Labs in a research report on Friday, November 21st. They issued a “hold” rating for the company. Northland Securities lifted their price target on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 9th. Wall Street Zen downgraded Astera Labs from a “buy” rating to a “hold” rating in a report on Tuesday, November 11th. Finally, BNP Paribas Exane assumed coverage on shares of Astera Labs in a report on Thursday, November 20th. They issued an “outperform” rating on the stock. Fifteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $195.89.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Loop Capital initiated coverage with a “Buy” and a $250 price target (roughly +100% upside vs. current levels), which can attract new buy-side interest and help lift sentiment. Benzinga
• Positive Sentiment: Recent quarterly results showed an EPS and revenue beat plus strong year-over-year revenue growth and positive guidance (Q1 EPS guide provided), supporting a fundamental growth story for the company and giving investors confidence in near-term execution. MarketBeat ALAB
• Positive Sentiment: Multiple sell-side firms have raised targets or maintain Buy/Outperform ratings (JPMorgan, Stifel, Northland, BNP Paribas Exane), and the consensus price target remains well above current trading levels—fuel for momentum traders and longer-term buyers. MarketBeat ALAB
• Neutral Sentiment: Media pieces are debating valuation and whether the stock is “too late” after strong 1‑year gains; these articles can drive retail interest but are mixed in directional impact. Yahoo Finance InsiderMonkey
• Neutral Sentiment: Reported short-interest figures in the feeds show contradictory/erroneous data (zeros and NaN values), so current short-interest signals are unreliable; treat these entries cautiously until corrected data is posted.
• Negative Sentiment: Insider selling: General Counsel Philip Mazzara sold 10,000 shares at about $117.47 (disclosed via SEC Form 4), reducing his ownership. Insider sales can be perceived negatively by some investors even if routine or for diversification/liquidity reasons. SEC Form 4

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.